FindTrial
Sign In

Multiple Boluses of Oral Tranexamic Acid to Reduce Hidden Blood Loss After primary medial unicompartmental knee arthroplasty Without Tourniquet: A Randomized Clinical Trial

Multiple Boluses of Oral Tranexamic Acid to Reduce Hidden Blood Loss After primary medial unicompartmental knee arthroplasty Without Tourniquet: A Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016960
Enrollment
Unknown
Registered
2018-07-04
Start date
2018-07-05
Completion date
Unknown
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unicompartmental knee arthroplasty:

Interventions

A:tranexamic acid 2g
B:tranexamic acid 2g+1g

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: patients with primary medial unicompartmental knee arthroplasty

Exclusion criteria

Exclusion criteria: The exclusion criteria are as follows: acute or chronic infection, a history of deep vein thrombosis (DVT) or pulmonary embolism (PE), hematologic diseases, cancer, and a preoperative hemoglobin level below 100 g/L.

Design outcomes

Primary

MeasureTime frame
blood loss;range of motion;inflammatory;—

Countries

China

Contacts

Public ContactBin Shen

West China Hospital, Sichuan University

wuyuangang23@163.com+86 18980601390

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026